A sweeping federal regulation set to take effect October 1st would fundamentally reshape how the government distributes more than $1 trillion in annual research grants—requiring that awards "demonstrably advance the President's policy priorities" rather than relying primarily on scientific merit and peer review.
Richard Besser, president and chief executive officer of the Robert Wood Johnson Foundation and former acting director of the Centers for Disease Control and Prevention, outlined the proposal's mechanics in a USA TODAY opinion piece published August 9th. Under the new rule, federal agency heads would gain authority to "designate" appointees to review grant awards before distribution, and peer review recommendations would no longer be "routinely deferred to." In plain terms: political considerations would precede scientific ones.
The regulation affects funding that currently supports medical research, vaccine clinics, disease outbreak responses, drug overdose prevention programs, veteran healthcare, and maternal health initiatives across hospitals, universities, nonprofits, and state and local health departments. Besser argued that grants could be terminated "simply for ideological reasons," halting promising research mid-stream.
The Institutional Problem
Besser cited real-world precedent. When wildfires devastated Southern California one year ago, destroying more than 18,000 homes and displacing more than 200,000 residents, President Donald Trump repeatedly threatened to condition federal disaster relief on California adopting unrelated policies, including more stringent voter identification laws. The Federal Emergency Management Agency then illegally withheld disaster relief grants from California and other states for months, according to Besser, until federal court orders forced the release of those dollars.
The pattern suggests how the new grant regulation might operate in practice: federal funds becoming leverage for political compliance rather than tools for addressing public health needs.
Scientific and Medical Objections
Opposition spans the medical establishment. The American Heart Association expressed "serious concerns about the independence of science and the future of biomedical and population-based research in the United States." The Academic Pediatric Association warned the rule "could limit federally funded research, training, innovation, care delivery and public health efforts that are essential to enhancing the health and well-being of all children."
Senator Susan Collins of Maine, the Republican chair of the Senate Appropriations Committee, predicted the regulation "would harm small and rural communities." Other detractors warned it could "jeopardize the future of cancer research," create "a detrimental impact" on diabetes prevention and treatment, "discourage and defund" research on health disparities, and generate funding insecurity for Native American tribal nations.
Besser noted that public comments submitted in response to the proposal are "overwhelmingly in opposition" across the political spectrum, reflecting what he described as widespread American concern for health independent of ideology.
The Broader Context
Besser placed this regulation within a larger pattern. Over the past 18 months, he wrote, the Trump administration has removed health insurance from millions, worked to dismantle the childhood vaccination schedule, terminated thousands of federal health officials, and slashed billions in funding to state and local health departments. Those moves, he noted, were conducted openly. This grant regulation, by contrast, represents what he called a "far more subversive approach."
The distinction matters. Direct policy changes invite legislative debate and public scrutiny. A regulation that empowers agency appointees to inject political judgment into peer-reviewed science operates with less visibility and potentially greater durability—a future White House, of any party, could inherit and expand these powers.
Why This Matters:
From a governance perspective, the rule raises fundamental questions about institutional independence and the separation between political authority and technical expertise. Federal research funding has historically operated under the principle that scientific merit, not political alignment, determines which projects advance. Reversing that principle creates two risks: first, that promising research gets defunded for political reasons, harming public health outcomes; second, that talented researchers and institutions migrate to private funding or foreign universities, weakening American scientific capacity. The California disaster relief precedent suggests the administration views federal funding as a tool for political leverage. If applied systematically to research grants, this approach could subordinate health policy to White House priorities rather than epidemiological evidence. Even officials within the Republican party, like Senator Collins, worry about harm to rural communities and institutional stability. Whether the regulation survives legal challenge or congressional pressure remains uncertain, but its existence signals a willingness to use administrative power to reshape how federal science operates.